Max Robotics — Global Service Robot Directory + US Certification

About

Holly Zurich is a pioneering surgical oncologist whose work has reshaped cancer care delivery during global health crises. Her key research areas include perioperative oncology, pandemic-resilient surgical pathways, and health systems innovation. Zurich’s most notable contribution is the development of the COVID-Minimal Cancer Surgery Pathway, a framework that allowed hospitals to maintain life-saving cancer surgeries during the COVID-19 pandemic while minimizing viral transmission risk. This work, published in 2020, has garnered 16 citations and was widely adopted as a blueprint for balancing urgent oncologic care with infection control. Her research demonstrates how evidence-based protocols can preserve surgical capacity without compromising patient or staff safety. Beyond this landmark paper, Zurich has advanced understanding of how to optimize surgical outcomes in resource-constrained environments. Her achievements include leading multi-institutional trials on surgical prioritization and receiving the Society of Surgical Oncology’s Innovation Award. By bridging clinical practice with public health preparedness, Zurich has provided a lasting model for resilient cancer care—a contribution that continues to inform pandemic recovery strategies worldwide.